To selectively target melanoma, the role of F-18- and Cu-64 labeled α–melanocyte-stimulating hormone analog to image melanoma by targeting melanocortin-1 receptors was evaluated [16–19] but showed limited success. This evidence concerns the gene MC1R and melanoma.